Status: current, Defined. Date: 31-Dec 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4011961000168112 | Esbriet (pirfenidone 267 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4011971000168118 | Esbriet 267 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Esbriet 267 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Esbriet 267 mg tablet | Is a | pirfenidone 267 mg tablet | true | Inferred relationship | Some | ||
| Esbriet 267 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Esbriet 267 mg tablet | Is a | Esbriet | true | Inferred relationship | Some | ||
| Esbriet 267 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Esbriet 267 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1963736215 | |
| Esbriet 267 mg tablet | has intended active ingredient | pirfenidone | true | Inferred relationship | Some | 1963736214 | |
| Esbriet 267 mg tablet | has Australian BoSS | pirfenidone | true | Inferred relationship | Some | 1963736214 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Esbriet 267 mg tablet, 90 | has TPUU | True | Esbriet 267 mg tablet | Inferred relationship | Some | 1 |
| Esbriet 267 mg tablet, 90, bottle | has TPUU | True | Esbriet 267 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR